| Pioglitazone, etoricoxib, interferon-?, and metronomic capecitabine for ... - UroToday |
|
|
UroToday We enrolled 45 patients with metastatic renal cell carcinoma (RCC) at a progressive disease between March 2003 and April 2008 to assess the impact of an anti-inflammatory treatment regime in combination with metronomic low-dose chemotherapy. |